GK

Gowri Kusumanch

Active Director Director DIN 08104385
DIN 08104385 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Gowri Kusumanch

Data last updated:

Gowri Kusumanch is a Director at Arin Pharma Private Limited (since 2018). The company operates in Pharma. Arin Pharma Private Limited reported revenue of ₹9.3 Lakh (FY 2020).

DIN 08104385
Primary Designation Director
Industry Pharma
First Appointment 09 Apr 2018
Oldest Company Age 10 yrs
Largest company Arin Pharma Private Limited · ₹9.3 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arin Pharma Private Limited U52500AP2016PTC103264
Director09 Apr 20182016₹9.3 Lakh (FY 2020)Active

Board colleagues of Gowri Kusumanch

NameDINCompanyDesignation
Balamurali Krishna Kotakala08104334Arin Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Arin Pharma Private Limited
Premium access

Shareholding and investment profile for Gowri Kusumanch

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gowri Kusumanch

Gowri Kusumanch currently holds 1 directorship: Arin Pharma Private Limited (Director, since 09 Apr 2018, revenue ₹9.3 Lakh (FY 2020)).

Gowri Kusumanch was first appointed on 09 Apr 2018 as Director at Arin Pharma Private Limited.

The current boards of Gowri Kusumanch's companies include Balamurali Krishna Kotakala (Arin Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available